Prosperity7 Ventures, a venture capital fund, led a $47m Series B round in Full-Life Technologies, a fully integrated global radiotherapeutics company, with participation from Sky9 Capital, Summer Capital, and GuanghuaWutong Fund, Chengwei Capital, HongShan, and Junson Capital. "The financing reflects strong support from our new and existing investors of our strategy and faith in the significant progress we have made in just over two years to build a fully integrated radiopharmaceutical company. The funding will support our evolution into a clinical-stage company, the advancement of our pipeline programs, and the construction of a Good Manufacturing Practices (GMP) manufacturing facility," Julie Wu, Full-Life Technologies CFO.